Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab Plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings. - Kaburaki S; Tanaka T; Kamio K; Tanaka Y; Kasahara K; Terasaki Y; Seike M (Internal medicine (Tokyo, Japan), 2026)